/Medtronic%20Plc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. With a market cap of $119.1 billion, Medtronic operates through Cardiovascular, Medical Surgical, Neuroscience, and Diabetes segments.
Companies worth $10 billion or more are generally described as "large-cap stocks." Medtronic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. Medtronic innovates solutions that treat 70-plus health conditions, from Parkinson's to diabetes.